Arthrex, the Naples-based giant known for its sports med dominance, is making a bold leap into total joints by acquiring UK-based Corin Group for $330M.
This deal has been the talk of the industry whisper network for months, and now it's confirmed as I am hearing the internal announcement from employees. No official press release yet, but the implications are huge—Arthrex is positioning itself to challenge the big players in hips, knees, and beyond.
Details of Acquisition
The acquisition closed at around $330M, a figure that's notably less than Corin's outstanding debt of over $360M, much of ...
